Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease
NCT04912323 is an interventional trial sponsored by R3 Vascular Inc.. As of 21 Nov 2026, it is recruiting participants. It studies Atherosclerotic Lesion, Lower Extremity Claudication and 2 more conditions. The registry lists an enrollment of 30 participants at 7 sites in 3 countries. The registry lists a start date of 17 Aug 2021 and a primary completion date of 31 Dec 2026.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04912323 |
| Status | Recruiting |
| Study type | Interventional trial |
| Lead sponsor | R3 Vascular Inc. |
| Enrollment | 30 |
| Registered sites | 7 |
| Countries | 3 |
| Conditions | Atherosclerotic Lesion, Lower Extremity Claudication, Lower Extremity Ischemia and Peripheral Arterial Disease |
| Start | 17 Aug 2021 |
| Primary completion | 31 Dec 2026 |
| Study completion | 31 Dec 2031 |
| Last update posted | 9 Apr 2024 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Juan F Granada, MD
Cardiovascular Research Foundation (CRF)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Crchum Université Montreal
Montreal
Gilles Soulez, MDRecruiting - Hopital Saint-Francois D'Assise
Québec
Active, not recruiting - Toronto General Hospital
Toronto
Kong Teng Tan, MDRecruiting
- San Donato Hospital
Arezzo
Francesco Liistro, MDRecruiting - Maria Cecilia Hospital
Cotignola
Luis M Palena, MDRecruiting - Irccs Multimedica
Milan
Flavio Airoldi, MDRecruiting
- Medical University Graz
Graz
Marianne Brodmann, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04912323
Each answer restates registry values shown on this page.
What is NCT04912323?
NCT04912323 is an interventional trial sponsored by R3 Vascular Inc.. It studies Atherosclerotic Lesion, Lower Extremity Claudication and 2 more conditions.
Is NCT04912323 recruiting?
As of 21 Nov 2026, it is recruiting participants. 6 of its 7 sites list their own status as recruiting.
Who leads NCT04912323?
The registry names Juan F Granada, MD (principal investigator, Cardiovascular Research Foundation (CRF)) as the overall official.
Where does NCT04912323 run?
The registry lists 7 sites in 3 countries. Most sites are in these countries: Canada (3), Italy (3) and Austria (1).
When is NCT04912323 expected to complete?
The registry lists a primary completion date of 31 Dec 2026 and a study completion date of 31 Dec 2031. The sponsor last updated the record on 9 Apr 2024.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.